Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress

This is a single-center clinical trial of 20 COVID-19 patients aged 30 to 79 years being treated with 5 sessions of hyperbaric oxygen therapy at 2.0 ATA (90 minutes) at NYU Winthrop Hospital from March 31 to April 28, 2020.

“The results demonstrated the safety of hyperbaric oxygen among COVID-19 patients and strongly suggests the need for a well-designed, multi-center randomized control trial” <view study>